Serina Therapeutics, Inc.(SER) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights HUNTSVILLE, May 8, 2025 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. ("Serina") (NYSE American: SER), a clinical- stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today reported its financial results for the first quarter ended March 31, 2025, along with recent business highlights. "We are energized by the substantial progress and strengthened found ...